Market Tracker

03/24 5:16pm ET

Novogen Ltd (NASDAQ:NVGN)

1.39
Delayed Data
As of Mar 24
 +0.0048 / +0.35%
Today’s Change
1.36
Today|||52-Week Range
2.68
-4.79%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.39
Today’s open1.40
Day’s range1.36 - 1.40
Volume27,766
Average volume (3 months)32,187
Market cap$27.0M
Dividend yield--
Data as of 3:48pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)-8.87%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...+0.15+11.36%
VKTXViking Therapeutics ...+0.01+0.85%
AVIRAviragen Therapeutic...+0.01+2.15%
OHRPOHR Pharmaceutical I...+0.01+1.84%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts